| mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
| mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.0099 |
0.9 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.9 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.0086 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |